Who Supplies Dapagliflozin? Top Manufacturers & Their Global Buyers
India accounts for a significant share of global Dapagliflozin exports, with 254+ registered manufacturers shipping to buyers across 113+ countries — yet a handful of companies dominate the shipments. AJANTA PHARMA LIMITED holds the largest share at 15.6% (export value: $7.7M). Close behind, ALEMBIC PHARMACEUTICALS LIMITED (11.2%, $5.6M). INVENTIA HEALTHCARE LIMITED (7.4%, $3.7M). The Sankey diagram below maps every supplier's customer flow in detail. All figures are drawn from Indian Customs (DGFT) shipping bill records.
🏭 Market Analysis: Top Suppliers & Customer Networks
Comprehensive supplier network intelligence dashboard
Who Supplies Dapagliflozin? Top Manufacturers & Their Buyers
Flow of Dapagliflozin from leading Indian exporters to their key global customers
Supplier-Customer Network Analysis
Top Suppliers → Customer Networks
Dapagliflozin Supplier Network — Key Market Intelligence
The Dapagliflozin export market from India is led by AJANTA PHARMA LIMITED, which alone commands a 15.6% share, shipping $7.7M worth of product across 103 shipments. The second-largest exporter, ALEMBIC PHARMACEUTICALS LIMITED, contributes $5.6M (11.2%) to the overall market. Combined, the top two suppliers alone account for 26.9% of all Dapagliflozin exports, indicating a relatively concentrated supply base.
Across all 254 tracked manufacturers, the total Dapagliflozin export value stands at $49.5M from 5.1K shipments. The market average shipment value is $9.7K. The single largest buyer relationship in terms of trade value is AWAMEDICA, receiving $4.8M worth of product.
The combined buyer network spans 25 named purchasing companies, including AWAMEDICA, AWAMEDICA PESHAWA STREET, AYSA DENIZCILIK TIC. TUR. VE SAN. A, PLANET PHARMA SA, ROZ LOJISTIK ULUSLARARASI TASIMACIL and 20 others. These buyers represent pharmaceutical manufacturers, distributors, hospital procurement groups, and generic drug producers operating across multiple continents.
Market Analysis: Top Suppliers & Their Customer Networks
1AJANTA PHARMA LIMITED
AJANTA PHARMA LIMITED is the first-largest Dapagliflozin exporter from India, with a market share of 15.6% and a total export value of $7.7M across 103 shipments. Their average shipment value of $75.1K is above the market average of $9.7K, suggesting premium or bulk contract pricing.
AJANTA PHARMA LIMITED serves 5 named buyers in our database. AWAMEDICA is the dominant customer, accounting for 61.6% of this supplier's tracked business. Top customers include:
• AWAMEDICA — $4.8M across 63 shipments (61.6% of this supplier's total exports)
• AWAMEDICA PESHAWA STREET — $1.4M across 18 shipments (17.5% of this supplier's total exports)
• AYSA DENIZCILIK TIC. TUR. VE SAN. A — $846.5K across 11 shipments (10.9% of this supplier's total exports)
• PLANET PHARMA SA — $459.9K across 6 shipments (5.9% of this supplier's total exports)
• ROZ LOJISTIK ULUSLARARASI TASIMACIL — $317.4K across 4 shipments (4.1% of this supplier's total exports)
Key Insight: AJANTA PHARMA LIMITED's per-shipment value of $75.1K is 675% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.
2ALEMBIC PHARMACEUTICALS LIMITED
ALEMBIC PHARMACEUTICALS LIMITED is the second-largest Dapagliflozin exporter from India, with a market share of 11.2% and a total export value of $5.6M across 95 shipments. Their average shipment value of $58.5K is above the market average of $9.7K, suggesting premium or bulk contract pricing.
ALEMBIC PHARMACEUTICALS LIMITED serves 5 named buyers in our database. GROUPE AFFI is the dominant customer, accounting for 62.0% of this supplier's tracked business. Top customers include:
• GROUPE AFFI — $3.4M across 59 shipments (62.0% of this supplier's total exports)
• PHARMASCIENCE INC. — $674.0K across 12 shipments (12.1% of this supplier's total exports)
• MANTRA DISTRIBUTIONS INC — $670.6K across 11 shipments (12.1% of this supplier's total exports)
• PHARMASCIENCE INC. — $544.4K across 9 shipments (9.8% of this supplier's total exports)
• 1177 55e AvenueDorva — $222.8K across 4 shipments (4.0% of this supplier's total exports)
Key Insight: ALEMBIC PHARMACEUTICALS LIMITED's per-shipment value of $58.5K is 503% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.
3INVENTIA HEALTHCARE LIMITED
INVENTIA HEALTHCARE LIMITED is the third-largest Dapagliflozin exporter from India, with a market share of 7.4% and a total export value of $3.7M across 111 shipments. Their average shipment value of $33.0K is above the market average of $9.7K, suggesting premium or bulk contract pricing.
INVENTIA HEALTHCARE LIMITED serves 5 named buyers in our database. JAMP PHARMA CORPORATION. is the dominant customer, accounting for 52.1% of this supplier's tracked business. Top customers include:
• JAMP PHARMA CORPORATION. — $1.9M across 58 shipments (52.1% of this supplier's total exports)
• JAMP PHARMA CORPORATION. — $860.5K across 26 shipments (23.5% of this supplier's total exports)
• UNILAB, INC. — $581.8K across 18 shipments (15.9% of this supplier's total exports)
• DKSH MALAYSIA SDN BH — $160.0K across 5 shipments (4.4% of this supplier's total exports)
• HOVID BHD — $155.1K across 5 shipments (4.2% of this supplier's total exports)
Key Insight: INVENTIA HEALTHCARE LIMITED's per-shipment value of $33.0K is 241% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.
4MICRO LABS LIMITED
MICRO LABS LIMITED is the fourth-largest Dapagliflozin exporter from India, with a market share of 5.8% and a total export value of $2.9M across 442 shipments. Their average shipment value of $6.5K is below the market average of $9.7K, reflecting a high-volume, competitive pricing strategy.
MICRO LABS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:
• MICRO NOVA PHARMACEUTICALS IND — $1.0M across 158 shipments (35.8% of this supplier's total exports)
• SUED & FARGESA — $626.4K across 97 shipments (21.9% of this supplier's total exports)
• BROWN AND BURK PHILI — $488.5K across 76 shipments (17.1% of this supplier's total exports)
• AL-KAWKAB SCIENTIFIC — $388.1K across 60 shipments (13.6% of this supplier's total exports)
• PHILLIPS PHARMACEUTI — $329.2K across 51 shipments (11.5% of this supplier's total exports)
Key Insight: MICRO LABS LIMITED operates with high shipment frequency (442 shipments) at a per-shipment value of $6.5K, indicating a broad distribution network with many smaller, regular orders.
5CIPLA LIMITED
CIPLA LIMITED is the fifth-largest Dapagliflozin exporter from India, with a market share of 5.4% and a total export value of $2.7M across 96 shipments. Their average shipment value of $27.9K is above the market average of $9.7K, suggesting premium or bulk contract pricing.
CIPLA LIMITED serves 5 named buyers in our database. SINO UNIVERSAL PHARMACEUTICAL CO is the dominant customer, accounting for 53.8% of this supplier's tracked business. Top customers include:
• SINO UNIVERSAL PHARMACEUTICAL CO — $1.4M across 52 shipments (53.8% of this supplier's total exports)
• SINO UNIVERSAL PHARMACEUTICAL CO — $386.6K across 14 shipments (14.4% of this supplier's total exports)
• SINO UNIVERSAL PHARMACEUTICAL CO — $347.5K across 12 shipments (13.0% of this supplier's total exports)
• SINO UNIVERSAL PHARMACEUTICAL CO — $316.8K across 11 shipments (11.8% of this supplier's total exports)
• WORLDWIDE HEALTHCARE — $188.5K across 7 shipments (7.0% of this supplier's total exports)
Key Insight: CIPLA LIMITED's per-shipment value of $27.9K is 188% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.
6MACLEODS PHARMACEUTICALS LTD
MACLEODS PHARMACEUTICALS LTD is the fifth-largest Dapagliflozin exporter from India, with a market share of 5.4% and a total export value of $2.7M across 34 shipments. Their average shipment value of $78.1K is above the market average of $9.7K, suggesting premium or bulk contract pricing.
MACLEODS PHARMACEUTICALS LTD serves 5 named buyers in our database. MYLAN IRELAND LTD is the dominant customer, accounting for 94.0% of this supplier's tracked business. Top customers include:
• MYLAN IRELAND LTD — $2.5M across 32 shipments (94.0% of this supplier's total exports)
• ALGORITHM SAL — $63.1K across 1 shipments (2.4% of this supplier's total exports)
• MACLEODS PHARMACEUTI — $56.1K across 1 shipments (2.1% of this supplier's total exports)
• ALGORITHM — $20.4K across 0 shipments (0.8% of this supplier's total exports)
• SIN PHYU KYUN COMPAN — $20.0K across 0 shipments (0.8% of this supplier's total exports)
Key Insight: MACLEODS PHARMACEUTICALS LTD's per-shipment value of $78.1K is 706% above the market average of $9.7K, consistent with large-order contracts or value-added formulations.
From Indian Factories to Global Pharmacies — How Dapagliflozin Flows
Once Dapagliflozin leaves the manufacturing plants of companies like AJANTA PHARMA LIMITED and ALEMBIC PHARMACEUTICALS LIMITED, it travels to 5 destination markets with a combined import value of $49.5M. Canada absorbs the largest share at 25.9% ($12.8M), followed by Iraq (17.2%) and China (5.6%).
In Canada — the top destination — named importers include GROUPE AFFI, JAMP PHARMA CORPORATION, AURO PHARMA INC. In Iraq, key buyers are AWAMEDICA, AWAMEDICA PESHAWA STREET, AYSA DENIZCILIK TIC. TUR. VE SAN. A.
This geographic spread reflects Dapagliflozin's role as an essential active pharmaceutical ingredient (API) and finished dosage form — sourced primarily from India due to its cost-competitive, WHO-compliant manufacturing base. The Sankey diagram below maps these destination countries to their named importers in detail.
🌍 Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Where Does Dapagliflozin Go? Top Importing Countries & Their Buyers
Trade flow of Dapagliflozin exports from India — top destination countries and the named companies importing it
Geographic Market Flow Analysis
Top Countries → Global Importers
Market Analysis: Top Importing Countries & Their Importers
1Canada
Canada ranks as the first-largest destination for Dapagliflozin imports from India, with a total trade value of $12.8M across 228 shipments — representing a 25.9% share of all Dapagliflozin exports. The average shipment value of $56.2K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 8 tracked buyers.
Named Dapagliflozin importers in Canada: GROUPE AFFI is the largest buyer, accounting for 27.0% ($3.5M) of this market's total imports.
• GROUPE AFFI — $3.5M (27.0% of Canada's total)
• JAMP PHARMA CORPORATION — $2.3M (17.8% of Canada's total)
• AURO PHARMA INC — $1.3M (10.4% of Canada's total)
Key Insight: Canada's per-shipment average of $56.2K (480% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Canada is a key market for Dapagliflozin imports from India.
2Iraq
Iraq ranks as the second-largest destination for Dapagliflozin imports from India, with a total trade value of $8.5M across 79 shipments — representing a 17.2% share of all Dapagliflozin exports. The average shipment value of $108.0K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.
Named Dapagliflozin importers in Iraq: AWAMEDICA is the largest buyer, accounting for 58.1% ($5.0M) of this market's total imports.
• AWAMEDICA — $5.0M (58.1% of Iraq's total)
• AWAMEDICA PESHAWA STREET — $1.4M (15.8% of Iraq's total)
• AYSA DENIZCILIK TIC. TUR. VE SAN. A — $846.5K (9.9% of Iraq's total)
Key Insight: Iraq's per-shipment average of $108.0K (1014% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Iraq is a key market for Dapagliflozin imports from India.
3China
China ranks as the third-largest destination for Dapagliflozin imports from India, with a total trade value of $2.8M across 19 shipments — representing a 5.6% share of all Dapagliflozin exports. The average shipment value of $145.2K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Dapagliflozin importers in China: SINO UNIVERSAL PHARMACEUTICAL CO is the largest buyer, accounting for 52.3% ($1.4M) of this market's total imports.
• SINO UNIVERSAL PHARMACEUTICAL CO — $1.4M (52.3% of China's total)
Key Insight: China's per-shipment average of $145.2K (1398% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
China is a key market for Dapagliflozin imports from India.
4Netherlands
Netherlands ranks as the fourth-largest destination for Dapagliflozin imports from India, with a total trade value of $2.5M across 10 shipments — representing a 5.0% share of all Dapagliflozin exports. The average shipment value of $249.7K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Dapagliflozin importers in Netherlands: MYLAN IRELAND LTD is the largest buyer, accounting for 100.0% ($2.5M) of this market's total imports.
• MYLAN IRELAND LTD — $2.5M (100.0% of Netherlands's total)
Key Insight: Netherlands's per-shipment average of $249.7K (2475% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Netherlands is a key market for Dapagliflozin imports from India.
5Philippines
Philippines ranks as the fifth-largest destination for Dapagliflozin imports from India, with a total trade value of $2.4M across 4 shipments — representing a 4.8% share of all Dapagliflozin exports. The average shipment value of $593.7K is above the global average of $9.7K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.
Named Dapagliflozin importers in Philippines: UNILAB, INC. is the largest buyer, accounting for 24.5% ($581.8K) of this market's total imports.
• UNILAB, INC. — $581.8K (24.5% of Philippines's total)
Key Insight: Philippines's per-shipment average of $593.7K (6024% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.
Philippines is a key market for Dapagliflozin imports from India.
People Also Ask — Dapagliflozin Supplier & Trade Network
Who are the top suppliers of Dapagliflozin from India?+
Which companies buy Dapagliflozin from Indian manufacturers?+
Where does Dapagliflozin exported from India go?+
What is the market share of the top Dapagliflozin supplier from India?+
What is the average shipment value for Dapagliflozin exports from India?+
Is Dapagliflozin manufactured in India and exported globally?+
Which country imports the most Dapagliflozin from India?+
Who are the buyers of Dapagliflozin in Iraq?+
How concentrated is the Dapagliflozin supplier market in India?+
How do I find verified buyers for Dapagliflozin in specific countries?+
Dapagliflozin Trade Network — Key Takeaways
- 1AJANTA PHARMA LIMITED is India's dominant Dapagliflozin exporter with a 15.6% market share and $7.7M in total exports — making it the single most important sourcing entity in this market.
- 2The top 254 suppliers collectively account for 50.8% of all tracked Dapagliflozin exports, with a combined trade value of $49.5M.
- 3Canada is the largest destination market, absorbing 25.9% of India's Dapagliflozin exports ($12.8M). Iraq (17.2%) and China (5.6%) follow.
- 4With 5.1K total shipments averaging $9.7K each, the Dapagliflozin export trade from India reflects both bulk API supply and finished dosage form distribution.
- 5Verified buyers across the network include AWAMEDICA, AWAMEDICA PESHAWA STREET, GROUPE AFFI, PHARMASCIENCE INC. — representing a diverse base of pharmaceutical importers, distributors, and generic drug manufacturers globally.
Network Overview
Supplier Network
Country Network
Network Insights
Top supplier: 5 customers
6 suppliers → 113 countries
Network value: $49.5M
Related Analysis
Market Intelligence
Latest developments and market context
Detailed market intelligence for Dapagliflozin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Dapagliflozin.
- 2.Flow Mapping: 254 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
- 3.Value Aggregation: Trade value per supplier-buyer link aggregated from 5,104 individual shipment records. Values are FOB in USD.
- 4.Geographic Clustering: Buyer networks clustered across 113 destination countries to identify geographic concentration patterns.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
5,104 Verified Shipments
254 manufacturers in network
Expert-Reviewed
By pharmaceutical trade specialists